AGGRESSIVE NK CELL LEUKEMIA
Clinical trials for AGGRESSIVE NK CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new AGGRESSIVE NK CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for AGGRESSIVE NK CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug DR-01 targets rare blood cancers in first human trial
Disease control Recruiting nowThis study tests a new drug called DR-01 in adults with rare types of leukemia or lymphoma. The goal is to see if it is safe and can shrink tumors. About 200 people will take part in this early-phase trial.
Matched conditions: AGGRESSIVE NK CELL LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Dren Bio • Aim: Disease control
Last updated May 26, 2026 09:03 UTC
-
Massive T-Cell lymphoma database aims to unlock better treatments
Knowledge-focused Recruiting nowThis study is creating a large database of information from 1,000 people with T-cell lymphoma. Researchers will collect medical records and tumor samples to learn more about the disease and how to improve care. No new treatments are being tested; the goal is to gather data for fu…
Matched conditions: AGGRESSIVE NK CELL LEUKEMIA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC